>
Switch to:

Sorrento Therapeutics EV-to-Revenue

: 39.22 (As of Today)
View and export this data going back to 2007. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sorrento Therapeutics's enterprise value is $1,824.33 Mil. Sorrento Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 was $46.52 Mil. Therefore, Sorrento Therapeutics's EV-to-Revenue for today is 39.22.

NAS:SRNE' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.93   Med: 54.56   Max: 6830.64
Current: 39.22

0.93
6830.64

During the past 13 years, the highest EV-to-Revenue of Sorrento Therapeutics was 6830.64. The lowest was 0.93. And the median was 54.56.

NAS:SRNE's EV-to-Revenue is ranked lower than
61% of the 931 Companies
in the Biotechnology industry.

( Industry Median: 20.49 vs. NAS:SRNE: 39.22 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-05-18), Sorrento Therapeutics's stock price is $6.65. Sorrento Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2021 was $0.18. Therefore, Sorrento Therapeutics's PS Ratio for today is 37.15.


Sorrento Therapeutics EV-to-Revenue Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sorrento Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.94 2.02 17.27 25.12 49.20

Sorrento Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.96 44.89 72.41 49.20 49.02

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Sorrento Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Sorrento Therapeutics's EV-to-Revenue falls into.



Sorrento Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sorrento Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1824.331/46.52
=39.22

Sorrento Therapeutics's current Enterprise Value is $1,824.33 Mil.
Sorrento Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 was 9.007 (Jun. 2020 ) + 11.753 (Sep. 2020 ) + 11.505 (Dec. 2020 ) + 14.255 (Mar. 2021 ) = $46.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sorrento Therapeutics  (NAS:SRNE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sorrento Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.65/0.179
=37.15

Sorrento Therapeutics's share price for today is $6.65.
Sorrento Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2021 was 0.042 (Jun. 2020 ) + 0.046 (Sep. 2020 ) + 0.043 (Dec. 2020 ) + 0.048 (Mar. 2021 ) = $0.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sorrento Therapeutics EV-to-Revenue Related Terms


Sorrento Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)